We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
14.77%
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$82.6M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$78.3M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$57.7M
4
TER icon
Teradyne
TER
+$56.1M
5
ABBV icon
AbbVie
ABBV
+$52.9M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.1M
2
ZBH icon
Zimmer Biomet
ZBH
+$56.1M
3
NVDA icon
NVIDIA
NVDA
+$55.8M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$54.7M
5
EBAY icon
eBay
EBAY
+$40.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.89%
2 Technology 25.02%
3 Communication Services 8.75%
4 Financials 5.58%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOYU
226
DouYu International Holdings
DOYU
$139M
$4.8M 0.09%
70,223
-51,665
-42% -$4.44M
HSKA
227
DELISTED
Heska Corp
HSKA
$4.8M 0.09%
20,901
+10,439
+100% +$2.05M
ELAN icon
228
Elanco Animal Health
ELAN
$13.2B
$4.73M 0.09%
+136,322
New +$4.5M
GLUE icon
229
Monte Rosa Therapeutics
GLUE
$1.4B
$4.72M 0.09%
+208,068
New +$4.24M
CORT icon
230
Corcept Therapeutics
CORT
$12.4B
$4.69M 0.09%
213,080
-245,421
-54% -$5.46M
DYN icon
231
Dyne Therapeutics
DYN
$4.7B
$4.68M 0.09%
222,374
-160,119
-42% -$3.01M
COCH icon
232
Envoy Medical
COCH
$51.7M
$4.62M 0.09%
+475,000
New +$4.62M
MTEM
233
DELISTED
Molecular Templates, Inc.
MTEM
$4.58M 0.09%
39,031
-37,337
-49% -$4.89M
GH icon
234
Guardant Health
GH
$21.7B
$4.5M 0.08%
36,210
+9,997
+38% +$1.34M
RBOT
235
DELISTED
Vicarious Surgical
RBOT
$4.49M 0.08%
+15,000
New +$4.47M
OSI.U
236
DELISTED
Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
OSI.U
$4.46M 0.08%
+450,000
New +$4.48M
BMEA icon
237
Biomea Fusion
BMEA
$84.6M
$4.45M 0.08%
+284,977
New +$5.03M
LZ icon
238
LegalZoom.com
LZ
$1.35B
$4.42M 0.08%
+116,668
New +$4.42M
PDOT
239
DELISTED
Peridot Acquisition Corp. II
PDOT
$4.37M 0.08%
+450,000
New +$4.39M
INFN
240
DELISTED
Infinera Corporation Common Stock
INFN
$4.34M 0.08%
425,177
+44,407
+12% +$431K
OBIO icon
241
Orchestra BioMed
OBIO
$238M
$4.12M 0.08%
403,699
– –
STRO icon
242
Sutro Biopharma
STRO
$401M
$4.08M 0.08%
21,951
+354
+2% +$69.3K
DOCS icon
243
Doximity
DOCS
$3.76B
$4.07M 0.08%
+70,003
New +$3.93M
AVIR icon
244
Atea Pharmaceuticals
AVIR
$376M
$4.03M 0.08%
187,805
-27,868
-13% -$837K
NYT icon
245
New York Times
NYT
$12.1B
$4.03M 0.08%
+92,417
New +$4.11M
DGNU
246
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$4M 0.07%
400,000
– –
BKSY icon
247
BlackSky Technology
BKSY
$943M
$3.97M 0.07%
+49,622
New +$3.96M
TGTX icon
248
TG Therapeutics
TGTX
$7.96B
$3.96M 0.07%
101,980
-824,786
-89% -$32.4M
SRRK icon
249
Scholar Rock
SRRK
$5.67B
$3.94M 0.07%
136,359
-1,558
-1% -$47.7K
ZETA icon
250
Zeta Global
ZETA
$5.38B
$3.92M 0.07%
+466,668
New +$3.95M
8 9
10
11 12

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.

  • Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
  • Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
  • Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
  • Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
  • Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
  • Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
  • Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.